Plunkett Research Online: Idorsia

IDORSIA (IDRSF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Idorsia Ltd is a Switzerland-based biopharmaceutical company. It primarily engages in the discovering, developing and commercializing drugs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses o.....



Idorsia
Ticker: IDRSF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 41 588440000
Fax:
Address: Hegenheimermattweg 91
Allschwil, 4123 Switzerland

Map
Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
Contacts Description

Idorsia Ltd is a Switzerland-based biopharmaceutical company. It primarily engages in the discovering, developing and commercializing drugs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses o.....See More See More

Auditor: Ernst & Young Ltd
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: